Clinical Trial Update: OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of OSI-774 in African American patients with advanced and previously treated non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• OSI-774

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2014-11-07